BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 32058203)

  • 1. A 3-year observation of excessive daytime sleepiness after subthalamic deep brain stimulation in patients with Parkinson's disease.
    Jung YJ; Kim HJ; Lee WW; Ehm G; Jeon B
    Clin Neurol Neurosurg; 2020 May; 192():105721. PubMed ID: 32058203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of bilateral subthalamic nucleus stimulation on sleep in patients with Parkinson's disease.
    Choi JH; Kim HJ; Lee JY; Yoo D; Im JH; Paek SH; Jeon B
    PLoS One; 2019; 14(8):e0221219. PubMed ID: 31454366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative analysis of the effect of bilateral subthalamic nucleus-deep brain stimulation on subjective and objective sleep parameters in Parkinson's disease.
    Yin Z; Bai Y; Guan B; Jiang Y; Wang Z; Meng F; Yang A; Zhang J
    Sleep Med; 2021 Mar; 79():195-204. PubMed ID: 33208282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bilateral subthalamic nucleus stimulation on sleep, daytime sleepiness, and early morning dystonia in patients with Parkinson disease.
    Lyons KE; Pahwa R
    J Neurosurg; 2006 Apr; 104(4):502-5. PubMed ID: 16619652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of specific components of sleep disturbances by simultaneous subthalamic and nigral stimulation in Parkinson's disease.
    Hidding U; Gulberti A; Pflug C; Choe C; Horn A; Prilop L; Braaß H; Fründt O; Buhmann C; Weiss D; Westphal M; Engel AK; Gerloff C; Köppen JA; Hamel W; Moll CKE; Pötter-Nerger M
    Parkinsonism Relat Disord; 2019 May; 62():141-147. PubMed ID: 30616868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of 24-month bilateral subthalamic stimulation on quality of sleep in Parkinson's disease.
    Dafsari HS; Ray-Chaudhuri K; Ashkan K; Sachse L; Mahlstedt P; Silverdale M; Rizos A; Strack M; Jost ST; Reker P; Samuel M; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Timmermann L;
    J Neurol; 2020 Jun; 267(6):1830-1841. PubMed ID: 32152689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of restless legs syndrome after subthalamic stimulation in Parkinson's disease: a dopaminergic overstimulation?
    Marques A; Fantini ML; Morand D; Pereira B; Derost P; Ulla M; Debilly B; Lemaire JJ; Durif F
    Sleep Med; 2015 May; 16(5):583-8. PubMed ID: 25881920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Deep Brain Stimulation on Sleep in Parkinson's Disease: An update.
    Zuzuárregui JRP; Ostrem JL
    J Parkinsons Dis; 2020; 10(2):393-404. PubMed ID: 32250316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.
    Dafsari HS; Silverdale M; Strack M; Rizos A; Ashkan K; Mahlstedt P; Sachse L; Steffen J; Dembek TA; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
    Mov Disord; 2018 Mar; 33(3):421-430. PubMed ID: 29465787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep-wake functions and quality of life in patients with subthalamic deep brain stimulation for Parkinson's disease.
    Bargiotas P; Eugster L; Oberholzer M; Debove I; Lachenmayer ML; Mathis J; Pollo C; Schüpbach WMM; Bassetti CL
    PLoS One; 2017; 12(12):e0190027. PubMed ID: 29253029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of STN DBS for Parkinson's disease on restless legs syndrome and other sleep-related measures.
    Chahine LM; Ahmed A; Sun Z
    Parkinsonism Relat Disord; 2011 Mar; 17(3):208-11. PubMed ID: 21216651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson's disease: results at the 36-month follow-up.
    Jost ST; Sauerbier A; Visser-Vandewalle V; Ashkan K; Silverdale M; Evans J; Loehrer PA; Rizos A; Petry-Schmelzer JN; Reker P; Fink GR; Franklin J; Samuel M; Schnitzler A; Barbe MT; Antonini A; Martinez-Martin P; Timmermann L; Ray-Chaudhuri K; Dafsari HS;
    J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):687-694. PubMed ID: 32371534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eight-year follow-up outcome of subthalamic deep brain stimulation for Parkinson's disease: Maintenance of therapeutic efficacy with a relatively low levodopa dosage and stimulation intensity.
    Jiang L; Chen W; Guo Q; Yang C; Gu J; Xian W; Liu Y; Zheng Y; Ye J; Xu S; Hu Y; Wu L; Chen J; Qian H; Fu X; Liu J; Chen L
    CNS Neurosci Ther; 2021 Nov; 27(11):1366-1373. PubMed ID: 34350691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
    Dafsari HS; Martinez-Martin P; Rizos A; Trost M; Dos Santos Ghilardi MG; Reddy P; Sauerbier A; Petry-Schmelzer JN; Kramberger M; Borgemeester RWK; Barbe MT; Ashkan K; Silverdale M; Evans J; Odin P; Fonoff ET; Fink GR; Henriksen T; Ebersbach G; Pirtošek Z; Visser-Vandewalle V; Antonini A; Timmermann L; Ray Chaudhuri K;
    Mov Disord; 2019 Mar; 34(3):353-365. PubMed ID: 30719763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep brain stimulation of pedunculopontine tegmental nucleus: role in sleep modulation in advanced Parkinson disease patients: one-year follow-up.
    Peppe A; Pierantozzi M; Baiamonte V; Moschella V; Caltagirone C; Stanzione P; Stefani A
    Sleep; 2012 Dec; 35(12):1637-42. PubMed ID: 23204606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilateral subthalamic nucleus deep brain stimulation improves sleep quality in Parkinson's disease.
    Amara AW; Standaert DG; Guthrie S; Cutter G; Watts RL; Walker HC
    Parkinsonism Relat Disord; 2012 Jan; 18(1):63-8. PubMed ID: 21924664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of indirect and direct targeted STN DBS in the treatment of Parkinson's disease-surgical method and clinical outcome over 15-year timespan.
    Lahtinen MJ; Haapaniemi TH; Kauppinen MT; Salokorpi N; Heikkinen ER; Katisko JP
    Acta Neurochir (Wien); 2020 May; 162(5):1067-1076. PubMed ID: 32103343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
    Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Subthalamic Deep Brain Stimulation on Sleep-Wake Behavior: A Prospective Electrophysiological Study in 50 Parkinson Patients.
    Baumann-Vogel H; Imbach LL; Sürücü O; Stieglitz L; Waldvogel D; Baumann CR; Werth E
    Sleep; 2017 May; 40(5):. PubMed ID: 28369624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.